<DOC>
	<DOCNO>NCT02406937</DOCNO>
	<brief_summary>180 qualified subject age 7 day 90 day enrol 144 complete study ( allow 20 % drop-out rate ) . Subjects randomly assign 3 group , include breast feeding , commercial new formula group . Study intervention 12 week .</brief_summary>
	<brief_title>New Stage 1 Formula Gut Comfort Gut Health</brief_title>
	<detailed_description>Primary objective : 1 . Improvement gut health infant comfort Secondary objectiveï¼š 1 . Efficacy easy digestion ; 2 . Changes SCFA feces ( Baseline Endpoint ) 3 . Improvement gut microbiome strain ( Baseline Day 21 ) ; ( bifidobacterium/lactobacillus/clostridium perfringens recommend ) 4 . Changes sIgA feces ( Baseline Endpoint ) 5 . Improvement tolerance ( comfort ) via infant fussy/bloating/abdominal pain/milk regurgitation/sleeping time ; 6 . Incidence eczema duration ; 7 . Infants growth</detailed_description>
	<criteria>Infants age 790 day ; Fed breast milk enrollment ; Parent legal guardian fully understand purpose requirement , include potential risk side effect study ; Willing participate study comply procedure ; Concent form sign parent . Twins , multiple birth , low birth weight child , birth weight child early birth child gestational age le 37 week ; Think need exclude Csection deliver infant ? It 's often majority birth Chinese tier1 city , probably make study recruitment slow , postpone study . The microflora Csection infant know different compare normally born infant . At least , mode delivery note calculated primary secondary outcome measurement potential confound factor During pregnancy , mother pregnancy complication disease may affect result ; Having serious disease may affect study intervention , neonatal sepsis , pneumonia ( associate respiratory failure ) , heart failure disease ; Having neonatal diarrhea acute respiratory infection within 48hours enrollment ; Having potential metabolic disease , chronic disease , congenital malformation , central nervous system disorder , neuromuscular disorder diseases affect bone metabolism may affect growth study result ; Having take food contain prebiotics probiotic tithe 15 day enrollment ; Having gluten allergy ( celiac disease ) ; Body weighttoheight Zvalue &lt; 3 accord standard WHO ; Receiving hormone therapy intravenous nutrition ; Lactose intolerance allergic ingredient study product ; Have participate clinical study within 3 month prior date screening ; Unable comply study schedule .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>90 Days</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>